BABAK TOUSI

Allopathic & Osteopathic Physicians|Internal Medicine|Geriatric Medicine CLEVELAND, OH NPI 1720074495

General Payments — all program years on this page

$166,040.26

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 227
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $32,425.16 across 39 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Travel and Lodging $16,220.0011
Consulting Fee $13,707.503
Food and Beverage $1,547.6624
Honoraria $950.001

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
Novo Nordisk AS $19,905.185
EISAI INC. $9,868.8922
Janssen Research & Development, LLC $1,453.158
Lundbeck LLC $1,087.502
Novo Nordisk AS $87.711
Lilly USA, LLC $22.731

By program year

Program yearAmountRecords
2018 $7,422.9515
2019 $12,197.8830
2020 $3,405.753
2021 $19,045.8216
2022 $68,115.5796
2023 $23,427.1328
2024 $32,425.1639

Records — PY2024 (39)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1077588817 Janssen Research & Development, LLC $19.23 09/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1077588821 Janssen Research & Development, LLC $213.67 09/19/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1077588823 Janssen Research & Development, LLC $347.79 09/19/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1077588829 Janssen Research & Development, LLC $38.44 09/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1077588837 Janssen Research & Development, LLC $52.86 09/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1077588841 Janssen Research & Development, LLC $142.41 09/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1077588843 Janssen Research & Development, LLC $19.23 09/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1077588845 Janssen Research & Development, LLC $619.52 09/20/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1096551979 Novo Nordisk AS $228.73 06/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1096552031 Novo Nordisk AS $389.12 06/20/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1096552741 Novo Nordisk AS $12,799.38 06/20/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1096552793 Novo Nordisk AS $6,187.50 06/20/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1096553191 Novo Nordisk AS $300.45 06/20/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1097352529 Novo Nordisk Inc $87.71 07/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1110732530 Eisai Inc. $4,700.00 04/03/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1110732532 Eisai Inc. $553.09 04/03/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1110732534 Eisai Inc. $19.00 08/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1110732536 Eisai Inc. $55.00 08/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1110732538 Eisai Inc. $98.00 08/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1110732540 Eisai Inc. $42.00 08/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1110732542 Eisai Inc. $2,820.00 09/04/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1110732544 Eisai Inc. $203.64 09/04/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1110732546 Eisai Inc. $118.01 09/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1110732548 Eisai Inc. $51.98 09/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1110732550 Eisai Inc. $47.25 09/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1110732552 Eisai Inc. $22.95 09/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1110732554 Eisai Inc. $372.00 09/10/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1110732556 Eisai Inc. $36.59 09/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1110732558 Eisai Inc. $24.30 09/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1110732560 Eisai Inc. $210.67 09/10/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1110732562 Eisai Inc. $116.52 09/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1110732564 Eisai Inc. $43.69 09/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1110732566 Eisai Inc. $49.95 09/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1110732568 Eisai Inc. $49.28 09/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1110732570 Eisai Inc. $24.30 09/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1110732572 Eisai Inc. $210.67 09/11/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1136061622 Lilly USA, LLC $22.73 08/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1145976087 Lundbeck LLC $137.50 11/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1145976089 Lundbeck LLC $950.00 12/17/2024 Honoraria Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.